Page last updated: 2024-08-24

cephalosporin c and imipenem, anhydrous

cephalosporin c has been researched along with imipenem, anhydrous in 406 studies

Research

Studies (406)

TimeframeStudies, this research(%)All Research%
pre-199079 (19.46)18.7374
1990's145 (35.71)18.2507
2000's91 (22.41)29.6817
2010's61 (15.02)24.3611
2020's30 (7.39)2.80

Authors

AuthorsStudies
Girlich, D; Leclercq, R; Naas, T; Nordmann, P1
Anderson, KC; Kellogg, GE; Sarkar, A1
Hanberger, H1
Nikoskelainen, J1
Dolna, I; Ruczkowska, J1
Allard, S; Auger, F; Bisson, C; Daviau, N; Drapeau, C; LeBel, M; Paradis, D; Vallée, F1
Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Rosina, M; Tajana, A; Trabucchi, E1
Katsu, K; Watanabe, N1
Hiruma, R; Katsu, K; Watanabe, N1
Edlund, C; Hedberg, M; Lindqvist, L; Nord, CE; Rylander, M1
Inoue, E; Iyobe, S; Katsu, K; Mitsuhashi, S; Watanabe, M1
Harabe, E; Kanazawa, K; Kawai, Y; Nishino, T; Otsuki, M1
Hopkins, JA; Lami, JL; Wilson, SE1
Cherubin, CE; Eng, RH; Smith, SM; Tan, EN1
Andrews, JM; Baldwin, DR; Cooper, MA; Thornber, D; Wise, R1
Knothe, H; Shah, PM1
Hanberger, H; Maller, R; Nilsson, LE; Nilsson, M1
Barrett, MS; Briggs, BM; Erwin, ME; Johnson, DM; Jones, RN1
Mitsuhashi, S; Sumita, Y1
Ishii, J; Lei, Y; Nakae, T; Satake, S1
Briedigkeit, H; Halle, E1
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R1
Charak, BS; Louie, R; Malloy, B; Mazumder, A; Twomey, P1
Igari, J2
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP1
Cunningham, MD; Darveau, RP1
Pizzo, PA; Rubin, M1
Mitsuhashi, S; Yoshida, M1
Ikemoto, H1
Inoue, M; Matsui, H; Okubo, T; Sakurai, N; Tsunoda, M1
Fujita, S; Tonohata, A1
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G1
Rosenblatt, JE1
McCracken, GH; Mustafa, MM1
Beumer, H; Hoepelman, IM; Rozenberg-Arska, M; Verhoef, J; Visser, MR1
Labia, R; Morand, A; Sirot, D; Sirot, J; Thabaut, A; Tiwari, K1
Karrer, FM; Lilly, JR; Rothenberg, SS; Schroter, GP1
Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E1
Morooka, T; Oda, T; Shigeoka, H1
Traub, WH1
Klastersky, J; Van der Auwera, P1
Forsgren, A; Persson, KM1
Chin, NX; Labthavikul, P; Neu, HC1
Brickley, X; Duval, J; Legrand, P; Orsoni, A; Soussy, CJ1
Drusano, GL; Schimpff, SC; Standiford, HC1
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T1
Andrews, JM; Piddock, LJ; Wise, R1
Chin, NX; Neu, HC; Novelli, A1
Perronne, C; Vildé, JL1
Jorgensen, JH; Maher, LA; Ramirez, PE; Redding, JS1
Andrew, JH; Downes, J1
Bakken, JS; Clark, RB; Hori, M; Sanders, CC1
Amicosante, G; Frère, JM; Galleni, M1
Adelman, DC; Beall, GN; Rohr, AS; Saxon, A1
Chin, NX; Neu, HC2
Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV1
Neu, HC4
Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV1
Roselle, GA1
Cynamon, MH; Palmer, GS; Sorg, TB1
Craig, WA; Gudmundsson, S; Vogelman, B1
Durgham, SM; Ishag, AJ; Shibl, AM1
Eley, A; Greenwood, D1
Pijck, J; Vuye, A1
Abbate, GF; Alagia, I; Cristiano, P; Giaquinto, E; Leonessa, V; Savioli, L1
Cullmann, W; Dick, W2
Starr, SE1
Bauernfeind, A1
Andrew, JH; Dixson, S1
Bannatyne, RM; Cheung, R1
Freimer, EH; Gilardi, GL; O'Donnell, ED; Raeder, R1
Cynamon, MH; Granato, PA1
Brown, JE; Collins, CD; Del Bene, VE1
Munro, R; Shanker, S; Toohey, M1
Gadebusch, HH; Shungu, DL; Weinberg, E1
Gilchrist, MJ; Spelhaug, DR; Washington, JA1
Cherubin, CE; Corrado, ML; Landesman, SH1
Verbist, L; Verhaegen, J1
Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C1
McCloskey, RV; Trent, JA; Tutlane, VA1
LeFrock, JL; Miller, MA; Vercler, MJ1
Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D1
Braveny, I; Elsser, R; Machka, K1
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ1
Neu, HC; Prince, AS1
Cherubin, CE; Corrado, ML; Gombert, ME; Shulman, M; Sierra, MF1
Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF1
Pranada, F; Pusztai-Markos, Z1
Finegold, SM; Owens, WE1
Meyer, RD; Pasiecznik, K1
McCracken, GH; Olsen, KD; Sakata, Y; Thomas, ML1
Bal, M; Panja, K; Ray, B1
Finan, M; Miller, MA; Yousuf, M1
Alford, RH; Brown, TH1
Alford, RH1
Chau, PY; Ling, J; Ng, WS1
Elliott, TS; Greenwood, D1
Le Noc, D; Le Noc, P; Robert, J1
Ahonkhai, VI; Bokkenheuser, VD; Cherubin, CE; Mosenthal, AC; Shulman, MA; Sierra, MF1
Bertram, MA; Bruckner, DA; Young, LS1
Vuye, A2
Schoenewaldt, EF; Smith, GB1
Gutiérrez-Núñez, J; Harrington, PT; Ramirez-Ronda, CH1
Cynamon, MH; Palmer, GS2
Cobbs, CG; Ennis, DM1
Chahime, H; Guibert, M; Labrune, P; Odièvre, M; Petit, J1
Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F1
Hikida, M; Kawashima, K; Mitsuhashi, S; Nishiki, K; Yamazaki, Y; Yoshida, M1
Diaz, E; Garcia-Curiel, A; Infante, P; Lopez, JD; Muñoz, M; Silva, JJ; Soult, JA; Valderrabanos, ES1
Baquero, F; Cantón, R; García de Lomas, J; Gimeno, C; Liñares, J; Martínez-Beltrán, J; Tubau, F1
Chimura, T1
Munakata, K; Satoh, M; Takeuchi, H; Yoshida, O1
Jones, RN; Marshall, SA1
Kaufmann, ME; Mentis, AF; Tzelepi, E; Tzouvelekis, LS1
Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Galtier, M; Kinowski, JM; Wynn, N1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N1
Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T1
Blahová, J; Hupková, M; Krcméry, V1
Frère, JM; Ledent, P1
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R1
Abate, D; Antonacci, M; Izzo, S; Panella, S1
Spencer, RC1
Bonner, DP; Fung-Tomc, J; Kolek, B1
Greenfield, RA1
Kouda, M1
Freifeld, AG1
Hasegawa, T; Hirano, M; Imae, K; Imura, S; Kamachi, H; Kamei, H; Okita, T1
Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M1
Asvanich, K; Chongchitmate, A; Fugpholngam, V; Srimuang, S; Tanphaichitra, D1
Adachi, Y; Inoue, M; Kawakami, M; Matsuda, K; Nakamura, K1
Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C1
Bujdáková, H; Kallová, J; Kettner, M; Lausová, A1
Cisterna, R; Farga, MA; Garau, J; García-de-Lomas, J; Gimeno, C; Millás, E; Navarro, D; Savall, F1
Nakagawa, Y; Toyoguchi, T1
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T1
Komoto, A; Nishino, T; Otsuki, M1
Kato, H; Kato, N; Tanaka, Y; Tanaka-Bandoh, K; Ueno, K; Watanabe, K1
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S1
Choi, YJ; Hong, T; Kish, A; Millett, W; Ndamukong, J; Win, KK1
Appelbaum, PC; Jacobs, MR; Visalli, MA1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y1
Jiang, GZ; Kato, Y; Kido, N; Koide, N; Kusumi, A; Narita, K; Sugiyama, T; Takahashi, K; Yokochi, T1
Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA1
Bucklin, SE; Morrison, DC1
Aparicio, J; Gómez-Codina, J; Herranz, C; Llorca, C; Montalar, J; Munárriz, B; Oltra, A; Pastor, M1
Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI1
Akashi, K; Asayama, R; Gondo, H; Goto, T; Harada, N; Hayashi, S; Hisano, S; Ishikura, H; Kawasaki, C; Kozuru, M; Kumakawa, M; Morioka, E; Muta, K; Nakajima, H; Niho, Y; Nishimura, J; Okamura, T; Sawae, Y; Shibuya, T; Suehiro, Y; Suematsu, E; Uike, N; Yamasaki, K; Yamashita, S; Yufu, Y1
Matsumura, N; Minami, S; Mitsuhashi, S1
Okonogi, K; Tsuchimori, N; Yamazaki, T1
Adachi, Y; Fuse, A; Hashizume, T; Kato, E; Nagano, R; Nakagawa, S; Ohtake, N; Okamoto, O; Shibata, K1
Quentin, C; Tessier, F1
Blahová, J; Králiková, K; Krcméry, V; Kubonová, K1
Iaconis, JP; Nadler, HL; Pitkin, DH; Sheikh, W1
Hathorn, JW; Lyke, K1
Alfaro, DV; Barton, CP; Beverly, DT; Brucker, AJ; Hudson, SJ; Kasowski, EJ; King, LP; Lopez, JD1
Cabibbo, E; Corulli, M; Dima, F; Fallacara, C; Longo, M; Peroni, L; Pizzi, R; Pollara, PC; Ravizzola, G; Turano, A1
Chan, CH; Chan, TH; Ho, A; Lai, CK; Leung, R1
Buhr, HJ; Foitzik, T; Hotz, HG; Kinzig, M; Sörgel, F1
Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM1
Blahová, J; Hupková-Lesická, M; Králiková, K; Krcméry, V; Kubonová, K1
Klugman, KP; Koornhof, HJ1
Barthélémy, M; Hong, LT; Hornstein, M; Labia, R; Péduzzi, J; Sautjeau-Rostoker, C; Scavizzi, M; Vessières, A1
Dotters, DJ; James, AH; Katz, VL; Rogers, RG1
Hirata, Y; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kawaguchi, R; Kobayashi, I; Kumasaka, K; Matsuoka, K; Murakami, E; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Okamoto, E; Saeki, H; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uchida, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H1
D'Amico, DT; Ng, EW1
Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P1
Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY1
Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H1
Battles, A; Liu, QF; Liu, W; Louie, A; Miller, DA; Miller, MH; Sucke, AC1
Klastersky, J1
Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC1
Bhutta, ZA1
Curati, W; Lynn, WA; McLaughlin, JE; Ogg, G; Peters, M; Shaunak, S1
Mulin, B; Talon, D; Thouverez, M1
Eltahawy, AT1
Ben Hassen, A; Ben Redjeb, S; Kamoun, A; Mahjoubi, F1
Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV1
Awaya, Y; Fujiue, Y; Kodomari, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y1
Groeneveld, PH; Kwappenberg, KM; Mattie, H; van Dissel, JT; van Langevelde, P1
Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P1
Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B1
Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H1
Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P1
Bartoníková, N; Blahová, J; Hupková-Lesická, M; Králiková, K; Krcméry, V; Kubonová, K; Schäfer, V; Torsová, V1
Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H1
Gabriel, V; Garbino, J; Harbarth, S; Lew, D; Pittet, D1
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C1
Ahmed, A; Ahmed, QT; Hafiz, S; Majeed, H; Syed, S1
Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M1
Ho, SW; Hsueh, PR; Jan, IS; Luh, KT; Teng, LJ1
Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K1
Kinoshita, S; Kumagai, S1
Fujita, N; Kitaura, K; Oka, T; Satoh, S; Sohma, A; Toda, S; Wada, Y; Yamagishi, H1
Arbo, MD; Barefoot, L; Hariharan, R; Nathan, C; Snydman, DR; Weinstein, RA1
Black, DJ; Deliganis, S; Duchin, JS; Frick, PA; Fritsche, TR; McKee, WM1
Lawrence, C; Nauciel, C; Ronco, E1
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O1
Blondeau, JM; Borsos, S; Misfeldt, C; Suter, ME1
Hamilton-Miller, JM; Shah, S1
Berger, D; Heinemann, M; Möricke, A; Seidelmann, M; Trautmann, M; Zick, R1
Borja, J; Herreras, A1
Sato, S; Toriya, M; Tsuji, A; Yamaguchi, S1
Andrzejewska, E; Kaniasty, M; Szkaradkiewicz, A1
Ballow, CH; Forrest, A; Highet, VS; Schentag, JJ1
Chan, WC; Cheng, AF; Li, RC; Ling, JM; Schentag, JJ1
Gildon, KM; Norrby, SR1
Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T1
Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K1
Berger, D; Heinemann, M; Lorenz, I; Möricke, A; Schneider, M; Seidelmann, M; Steinbach, G; Trautmann, M1
Allerberger, F; Feierl, G; Hirschl, A; Krause, R; Mittermayer, H; Reisinger, EC; Wendelin, I1
Angus, BJ; Chaowagul, W; Howe, PA; Rajanuwong, A; Simpson, AJ; Smith, MD; Suputtamongkol, Y; Walsh, AL; White, NJ; Wuthiekanun, V1
Arita, K; Daido, K; Kohara, T; Nakamura, K; Ohashi, N; Takeshima, Y1
Chaowagul, W; Kurimoto, M; Lauw, FN; Prins, JM; Simpson, AJ; Smith, MD; Speelman, P; van der Poll, T; van Deventer, SJ; White, NJ1
Cho, JH; Jin, C; Jung, I; Kim, DH; Kim, M; Ku, HJ; Oh, CH; Yook, J1
Deblangy, C; Decré, D; Fichelle, A; Joly-Guillou, ML; Kosmann, MJ; Lucet, JC; Pernet, M; Régnier, B1
Kays, MB1
Iyobe, S; Kobayashi, I; Okubo, T; Takahashi, A; Tsunoda, M; Yomoda, S1
Angus, BJ; Chaowagul, W; Prins, JM; Simpson, AJ; Smith, MD; Suputtamongkol, Y; van Deventer, SJ; Weverling, GJ; White, NJ1
Fujimura, S; Gomi, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A; Yasui, S1
Deguchi, K; Endo, H; Ishihara, R; Matsumoto, Y; Nishinari, C; Suzuki, Y1
Bollet, C; Bornet, C; Bosi, C; Davin-Regli, A; Pages, JM1
Burgos, A; Campillos, P; Gonzalo, N; López-Lozano, JM; Monnet, DL; Saez, M; Yagüe, A1
Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O1
Horn, DL; Morrison, DC; Norimatsu, M; Silverstein, R; Wood, JG; Xue, Q1
Norrby, SR1
Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I1
Christenson, JC; Daly, JA; Korgenski, EK1
Ballesta, S; Benedí, VJ; Conejo, MC; Hernández-Allés, S; Martínez-Martínez, L; Pascual, A; Perea, EJ; Ramírez De Arellano-Ramos, E1
Lumbiganon, P; Panamonta, O1
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T1
Inoue, M; Matsuda, K1
Anderlik, P; Filetóth, Z; Máthé, A; Rókusz, L; Rozgonyi, F; Szabó, D1
Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J1
Barry, AL; Brown, SD; Fuchs, PC1
Chong, Y; Jang, SJ; Lee, HS; Lee, K; Lee, MH; Park, AJ; Song, WK1
Abe, T; Fukuoka, T; Inoue, H; Ohya, S1
Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH1
Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C1
Anthony, L; Appelbaum, PC; Credito, K; Ednie, LM; Hoellman, DB; Jacobs, MR; Kelly, LM1
Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K1
Chen, M; Xu, Y; Zhang, S1
Chen, M; Liu, J; Wang, C; Wang, H; Wang, P; Xie, X; Xu, Y; Yuan, Y; Zhang, X; Zhang, Y1
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E1
Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG1
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E2
Araake, M; Gotoh, N; Hiraishi, T; Miyata, A; Nishino, T; Ogawa, H; Takata, T1
Karp, MT; Kurittu, JS; Valtonen, SJ1
Jones, RN; Mutnick, AH; Turner, PJ1
Furugo, I; Ishida, M; Takii, M; Ueda, M1
Han, C; Jin, Y; Zhang, R1
Flores, C; Goldani, LZ; Hadlich, E; Maguilnik, I1
Blanco, G; de Mier, C; Famiglietti, A; Juárez, J; Pugliese, L; Rodríguez, CH; Vay, C1
Burgmann, H1
Beketov, AS; Komarov, RM; Pisarev, VV; Sidorenko, SV1
Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE1
Choi, TY; Chong, YS; Kang, JO; Kang, SH; Kim, EC; Kim, MY; Lee, KW1
Kadry, AA1
Aymon, D; Bally, F; Bille, J; Chiolero, R; Cometta, A; Garbino, J; Glauser, MP; Greub, G; Kinge, T; Krawczyk, L; Lew, D; Romand, JA; Rubinstein, E; Schaller, MD; Stratchounski, L; Zanetti, G1
Hashimoto, K; Ito, K; Ogata, H1
Choi, SH; Chung, JW; Hyong Kim, T; Kim, NJ; Kim, YS; Lee, SO; Ryu, J; Woo, JH1
Chong, Y; Hong, SG; Jang, SJ; Kim, M; Lee, HJ; Lee, K; Ryoo, N1
Hoshinaga, K; Ishikawa, K; Miyakawa, S; Naide, Y; Shiroki, R; Tanaka, T1
Bollet, C; Bornet, C; Davin-Régli, A; Pagès, JM; Thiolas, A1
Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K1
Chuang, CL; Tsai, SH; Wu, JJ; Yan, JJ1
Lee, WS; Lin, ML; Liu, CY; Wang, FD1
Bugnon, D; Caillon, J; Gras-Le Guen, C; Jacqueline, C; Kergueris, MF; Navas, D; Potel, G1
Cefalo, G; Massimino, M; Mazza, E; Scaramuzza, D; Spreafico, F1
Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P1
Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C1
Barie, PS; Dellinger, EP; Grasela, TH; Rotstein, OD; Walawander, CA1
Arnal, JM; Berger, P; Franceschini, B; Gainnier, M; Michel, F; Papazian, L; Sainty, JM1
Avilova, ND; Gordeev, IuN; Mitrokhin, SD; Sokolov, AA; Zabaznyĭ, NP1
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A1
Conejo, C; Ibáñez-Martínez, J; Martínez-Martínez, L; Pachón, J; Pachón-Ibañez, ME; Pascual, A; Pichardo, C; Rodríguez-Martínez, JM1
Kuti, JL; Nicolau, DP; Sun, HK1
Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G1
Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL1
Cheng, KC; Chuang, YC; Huang, GC; Wu, LT; Yu, WL1
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H1
Li, C; Nicolau, DP; Nightingale, CH; Ong, CT; Tessier, PR1
Konkoly-Thege, M; Kuti, JL; Ludwig, E; Nicolau, DP1
Bokaei, S; Etemadi, G; Feizabadi, MM; Rahmati, M; Shabanpoor, S; Yadegarinia, D1
Alp, E; Aygen, B; Metan, G; Sumerkan, B1
Elsa, V; María, A; Nieves, B; Ruíz, J; Ruiz, M; Salazar De Vegas, EZ; Vila, J1
Caviezel, A; Garbino, J; Lew, D; Matulionyte, R; Morel, P; Uckay, I; Villiger, P1
Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH1
Mammeri, H; Nordmann, P; Poirel, L1
Hoda, MQ; Hussein, K; Manasia, R; Salahuddin, N; Samad, A; Siddiqui, S; Zafar, A1
Bertoluci, DF; Dell'Aquilla, AM; López, KJ; Santos, SR; Vicente, KM1
Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH1
Cha, R1
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ1
Berkani, A; Eb, F; Mammeri, H; Nordmann, P1
Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F1
Daimon, Y; Tanaka, K; Watanabe, K1
Edmond, M; Harpe, SE; Johnson, C; Pakyz, A; Polk, RE; Powell, JP1
Ben Redjeb, S; Mbarek, M; Meddeb, B; Messadi, Aa; Thabet, L; Turki, A1
Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V1
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH1
Bou, G; Torres, E; Villanueva, R1
Arlet, G; Bakour, R; Dallenne, C; Geneste, D; Iabadene, H; Messai, Y1
Conejo, Mdel C; Hernández, JR; Pascual, A1
Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P1
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C1
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L1
Lee, HJ; Lee, KM; Suh, JT; Yang, HY1
Ge, Y; Juan, C; Moyá, B; Oliver, A; Zamorano, L1
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M1
Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA1
Jacobus, NV; McDermott, LA; Snydman, DR1
Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D1
Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M1
Bebrone, C; Docquier, JD; Favier, A; Ferrer, JL; Frère, JM; Galleni, M; Lassaux, P; Laurent, C; Loisel, E; Sohier, JS; Traoré, DA1
Kochhar, R; Noor, MT; Radhakrishna, Y; Ray, P; Singh, K; Sinha, SK; Wig, JD1
Appelbaum, PC; Armstrong, ES; Kosowska-Shick, K; Kubo, A; Lin, G; Pankuch, GA1
Cabot, G; Macia, MD; Martínez-Martínez, L; Moya, B; Ocampo-Sosa, AA; Oliver, A; Peña, C; Rodríguez, C; Suárez, C; Tubau, F; Zamorano, L1
Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö1
Gonçalves-Pereira, J; Póvoa, P1
Tuğrul, HM; Yıldırım, MI1
Kan, Y; Kartal, M; Orhan, IE; Ozcelik, B1
Aracil, B; Beceiro, A; Bou, G; Cercenado, E; Fernández, A; Kerff, F; Miro, E; Navarro, F; Oliver, A; Oteo, J; Pérez-Llarena, FJ; Zamorano, L1
Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L1
Fu, W; Lin, Z; Liu, Z; Zhang, B; Zhang, X1
Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA1
Mondal, A; Rajamohan, G; Srinivasan, VB; Vaidyanathan, V; Venkataramaiah, M1
Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP1
Al-Agamy, MH1
Goff, DA; Nicolau, DP1
Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN1
Chen, Z; Kang, M; Li, D; Tao, C; Wang, T; Xie, Y1
Bruchmann, S; Cabot, G; Haussler, S; Juan, C; Moyà, B; Mulet, X; Oliver, A; Zamorano, L1
Hayakawa, K; Kirikae, T; Kubota, S; Kuroda, E; Kutsuna, S; Mezaki, K; Miyoshi-Akiyama, T; Nagamatsu, M; Ohmagari, N; Shimada, K; Sugiki, Y; Takeshita, N; Tojo, M1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Potel, G1
de la Torre, J; Del Arco, A; Faus, V; Fernández, F; García-Alegría, J; Montiel, N; Olalla, J; Prada, JL; Rivas, F; Tortajada, B1
Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X1
Akiyama, N; Fukushima, T; Hatanaka, K; Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Nakane, T; Ohyashiki, K; Takahashi, T; Tamaki, T; Tamura, K; Tanimoto, M; Tatsumi, Y; Urabe, A; Yoshida, I1
Appalla, L; Koren, M; Kwak, YI; Lesho, EP; McGann, P; Ong, AC; Snesrud, E; Waterman, PE1
Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ1
Gentry, CA; Williams, RJ1
Rüegg, S; Sutter, R; Tschudin-Sutter, S1
Bhadoria, AS; Jindal, A; Kumar, M; Maiwall, R; Sarin, SK1
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F1
Srinivas, NR1
Brasca, M; Decimo, M; Silvetti, T1
Calfee, DP; Eiras, DP; Furuya, EY; Gomez-Simmonds, A; Jenkins, SG; Kubin, CJ; Loo, A; Nelson, B; Satlin, MJ; Whittier, S1
Chen, TL; Chuang, MF; Huang, WC; Kuo, SC; Lauderdale, TL; Lee, Y; Tseng, KC; Yang, YS1
Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M1
Ardebili, A; Azimi, L; Bijari, A; Fallah, F; Lari, AR; Lari, ER1
Chen, J; Kong, C; Zhang, Y; Zhu, L; Zou, X1
Lee, DG; Lee, SH; Lee, Y; Yoo, KH1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF1
Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J1
Gao, L; Li, Y; Lyu, Y1
D'Arcy, S; Doumith, M; Findlay, J; Hopkins, KL; Howe, R; Mather, B; Meunier, D; Mustafa, N; Pike, R; Woodford, N; Wootton, M1
Ambretti, S; Campoli, C; Gaibani, P; Giannella, M; Landini, MP; Lewis, RE; Re, MC; Viale, P; Volpe, SL1
Keller, PM; Müller, DM; Rominski, A; Sander, P; Schulthess, B1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Feng, H; Fleming, J; Liu, W; Liu, X; Wang, DC; Wang, S1
Alvarez, DN; Bayer, AS; Farah, S; Garcia-de-la-Maria, C; Miro, JM; Mishra, NN; Sakoulas, G; Zapata, B1
Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N1
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X1
Ishibashi, N; Ito, A; Ito-Horiyama, T; Nishikawa, T; Ota, M; Sato, T; Tsuji, M; Yamano, Y1
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A1
Hsueh, PR; Hsueh, SC; Huang, YT; Lee, YJ; Liao, CH; Tsuji, M1
Hu, L; Palzkill, T; Prasad, BVV; Sankaran, B; Sun, Z1
Goudarzi, G; Shakib, P1
Cox, JAG; Desai, M; Harrison, J; Lambert, PA; Lopeman, RC; Rathbone, DL1
Cabot, G; Fernández-Esgueva, M; Fraile-Ribot, PA; Huarte, R; López-Calleja, AI; Mulet, X; Oliver, A; Rezusta, A1
DePestel, DD; Karlowsky, JA; Lob, SH; Motyl, MR; Raddatz, J; Sahm, DF; Young, K1
Al-Hasan, MN1
Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H1
Canovas, J; Chau, F; Fantin, B; Le Monnier, A; Lefort, A; Petitjean, G1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E1
Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P1
Carvalhaes, CG; Castanheira, M; Sader, HS; Shortridge, D1
Castanheira, M; Duncan, LR; Mendes, RE; Sader, HS1
Arend, LNVS; Bail, L; Ito, CAS; Nogueira, KDS; Tuon, FF1
Cabot, G; Gomis-Font, MA; Juan, C; López-Argüello, S; Moyá, B; Oliver, A; Zamorano, L1
DeRyke, CA; Hilbert, DW; Karlowsky, JA; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Wong, MT; Young, K1
Batchelder, HR; Lamichhane, G; Nuermberger, EL; Panthi, CM; Rimal, B; Story-Roller, E; Tabor, C; Townsend, CA1
Amadesi, S; Ambretti, S; Gaibani, P; Lazzarotto, T1
Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Fraile-Ribot, PA; Galán-Sánchez, F; Guijarro-Sánchez, P; Lasarte-Monterrubio, C; Oliver, A; Rumbo-Feal, S; Vázquez-Ucha, JC1
Wang, Y; Zhang, W1
Findlay, J; Nordmann, P; Poirel, L; Rens, C1
Cheng, B; Guo, P; Jia, P; Xu, Y; Yang, Q; Zhang, H; Zhu, Y1
Haines, RR; Hammer, KA; Putsathit, P; Tai, AS1
Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z1
Abdulhemid Said, L; Muhsin, EA; Sajid Al-Jubori, S1
Kollef, MH; Windham, S1
Alekseeva, I; DeRyke, CA; Hawser, SP; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K1
Cabot, G; Khajehpour, M; Kim, K; Mark, BL; Oliver, A1
Arends, SJR; Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS; Shortridge, D1
Aja-Macaya, P; Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Fernández-González, A; Galán-Sánchez, F; González-Mayo, E; Guijarro-Sánchez, P; Lada-Salvador, P; Lasarte-Monterrubio, C; Martínez-Guitián, M; Muíño-Andrade, M; Oliver, A; Rodríguez-Iglesias, M; Rumbo-Feal, S; Vázquez-Ucha, JC; Vela-Fernández, R1
Hsueh, PR; Ko, WC; Lee, YL1

Reviews

22 review(s) available for cephalosporin c and imipenem, anhydrous

ArticleYear
[New cephalosporins and imipenem].
    Duodecim; laaketieteellinen aikakauskirja, 1991, Volume: 107, Issue:10

    Topics: Bacterial Infections; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; In Vitro Techniques

1991
Susceptibility testing of anaerobic bacteria.
    Clinics in laboratory medicine, 1989, Volume: 9, Issue:2

    Topics: Agar; Anti-Bacterial Agents; Bacteria, Anaerobic; Cephalosporins; Culture Media; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Quality Control

1989
Antimicrobial agents in pediatrics.
    Infectious disease clinics of North America, 1989, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Child; Child, Preschool; Cilastatin; Cystic Fibrosis; Humans; Imipenem; Infant; Tissue Distribution

1989
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl A

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin

1986
Immediate hypersensitivity reactions to beta-lactam antibiotics.
    Annals of internal medicine, 1987, Volume: 107, Issue:2

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Imipenem; Penicillins; Skin Tests; Thienamycins

1987
New antibiotics: areas of appropriate use.
    The Journal of infectious diseases, 1987, Volume: 155, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins

1987
Antimicrobial therapy of bacterial sepsis in the newborn infant.
    The Journal of pediatrics, 1985, Volume: 106, Issue:6

    Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Infant Mortality; Infant, Newborn; Penicillin Resistance; Penicillins; Sepsis; Thienamycins

1985
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Annual review of pharmacology and toxicology, 1982, Volume: 22

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam

1982
The newer cephalosporins. Aztreonam and imipenem.
    Infectious disease clinics of North America, 1995, Volume: 9, Issue:3

    Topics: Aztreonam; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Monobactams; Thienamycins

1995
Clinical pharmacokinetics during continuous haemofiltration.
    Clinical pharmacokinetics, 1994, Volume: 26, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Half-Life; Hemofiltration; Humans; Imipenem; Metabolic Clearance Rate; Pharmacokinetics; Protein Binding; Tissue Distribution; Ultrafiltration; Vancomycin

1994
Symposium on antimicrobial therapy. V. The carbapenems and monobactams.
    The Journal of the Oklahoma State Medical Association, 1993, Volume: 86, Issue:2

    Topics: Aztreonam; Bacterial Infections; Cephalosporins; Humans; Imipenem; Microbial Sensitivity Tests

1993
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
    Hematology/oncology clinics of North America, 1993, Volume: 7, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin

1993
Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Imipenem; Meropenem; Neutropenia; Thienamycins

1997
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
    Revue medicale de Bruxelles, 1997, Volume: 18, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins

1997
Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem.
    Scandinavian journal of infectious diseases, 1999, Volume: 31, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Clindamycin; Diarrhea; Drug Eruptions; Humans; Imipenem; Meningitis; Meropenem; Nausea; Seizures; Thienamycins; Thrombocytosis

1999
Carbapenems in serious infections: a risk-benefit assessment.
    Drug safety, 2000, Volume: 22, Issue:3

    Topics: Adult; Cephalosporins; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Tolerance; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Risk Assessment; Seizures; Thienamycins

2000
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
    The Cochrane database of systematic reviews, 2010, Nov-10, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins

2010
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
    Critical care (London, England), 2011, Volume: 15, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Infections; Meropenem; Piperacillin; Thienamycins

2011
Seizures as adverse events of antibiotic drugs: A systematic review.
    Neurology, 2015, Oct-13, Volume: 85, Issue:15

    Topics: Animals; Anti-Bacterial Agents; Central Nervous System; Cephalosporins; Humans; Imipenem; Risk; Seizures

2015
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines

2020
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin

2021
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?
    Current opinion in infectious diseases, 2022, 12-01, Volume: 35, Issue:6

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem

2022

Trials

22 trial(s) available for cephalosporin c and imipenem, anhydrous

ArticleYear
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
    The American surgeon, 1991, Volume: 57, Issue:12

    Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins

1991
[Short-term antibiotic prophylaxis in surgery].
    La Clinica terapeutica, 1993, Volume: 143, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cephalosporins; Child; Cilastatin; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Male; Middle Aged; Postoperative Period; Preoperative Care; Surgical Wound Infection

1993
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Revista medica de Chile, 1995, Volume: 123, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins

1995
Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Prospective Studies; Thienamycins

1996
[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Penicillins

1996
Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
    Respiration; international review of thoracic diseases, 1997, Volume: 64, Issue:3

    Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cilastatin; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Hong Kong; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Pneumonia, Bacterial; Protease Inhibitors; Survival Rate; Thienamycins

1997
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome

1997
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
    Archives of surgery (Chicago, Ill. : 1960), 1997, Volume: 132, Issue:12

    Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome

1997
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
    JAMA, 1998, Oct-14, Volume: 280, Issue:14

    Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1998
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis

1998
[Effects of prophylactic antibiotic agent on interleukin-6 level in open chest surgery--comparison between imipenem and flomoxef].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:9

    Topics: Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Cephalosporins; Humans; Imipenem; Interleukin-6; Middle Aged; Postoperative Complications; Postoperative Period; Thienamycins; Thoracic Surgical Procedures

1998
Comparison of imipenem and ceftazidime as therapy for severe melioidosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Melioidosis; Middle Aged; Prospective Studies; Thienamycins; Treatment Failure; Treatment Outcome

1999
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis.
    The Journal of infectious diseases, 1999, Volume: 180, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Interferon-gamma; Interleukin-12; Interleukin-15; Interleukin-18; Interleukins; Male; Melioidosis; Middle Aged; Thienamycins

1999
Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Biomarkers; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Cytokines; Female; Humans; Imipenem; Interleukin-10; Interleukin-6; Lactates; Logistic Models; Male; Melioidosis; Middle Aged; Prognosis; Thienamycins; Tumor Necrosis Factor-alpha

2000
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
    Critical care medicine, 2002, Volume: 30, Issue:2

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha

2002
[Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:3

    Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Clinical Trials as Topic; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Meropenem; Models, Economic; Sulbactam; Thienamycins

2003
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Cancer, 2003, Sep-01, Volume: 98, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin

2003
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Adult; Aged; APACHE; Cefepime; Cephalosporins; Cilastatin; Critical Care; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Protease Inhibitors; Respiration, Artificial; Thienamycins

2003
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome

2004
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Infection, 2007, Volume: 35, Issue:3

    Topics: Abdominal Cavity; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Hospitals, University; Humans; Imipenem; Male; Metronidazole; Middle Aged

2007
Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins; Young Adult

2015
A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Imipenem; India; Liver Cirrhosis; Male; Middle Aged; Paracentesis; Peritonitis; Risk Factors; Severity of Illness Index; Survival Analysis; Time Factors

2016

Other Studies

362 other study(ies) available for cephalosporin c and imipenem, anhydrous

ArticleYear
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity

2007
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
    European journal of medicinal chemistry, 2012, Volume: 52

    Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics

2012
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
    Scandinavian journal of infectious diseases. Supplementum, 1992, Volume: 81

    Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin

1992
[Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
    Przeglad lekarski, 1992, Volume: 49, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Microbial Sensitivity Tests

1992
Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:10

    Topics: Adult; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Half-Life; Humans; Imipenem; Male; Microbial Sensitivity Tests

1992
[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].
    Minerva chirurgica, 1992, Oct-31, Volume: 47, Issue:20

    Topics: Amikacin; Ampicillin Resistance; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance; Surgical Procedures, Operative; Time Factors

1992
Bactericidal activity of cefclidin (E1040) against Pseudomonas aeruginosa under conditions simulating plasma pharmacokinetics: lack of development of chromosomally-mediated resistance to beta-lactams.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:4

    Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Humans; Imipenem; Membrane Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1992
Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:5

    Topics: beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Isoelectric Focusing; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1992
Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:2

    Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Biotransformation; Cefoxitin; Cephalosporins; Edetic Acid; Humans; Hydrolysis; Imipenem; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Weight; Penicillins

1992
In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:3

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1992
In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
    Drugs under experimental and clinical research, 1992, Volume: 18, Issue:2

    Topics: Animals; Bacterial Infections; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Thienamycins

1992
An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Cycle; Cephalosporins; Colony Count, Microbial; Diffusion; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Mice; Microbial Sensitivity Tests

1991
In-vitro activity and beta-lactamase stability of SR 44337, a new long acting cephalosporin.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:2

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Ceftriaxone; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Stability; Imipenem

1991
The in vitro activity of flomoxef compared to four other cephalosporins and imipenem.
    Infection, 1991, Volume: 19 Suppl 5

    Topics: Cephalosporins; Imipenem; Microbial Sensitivity Tests

1991
Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:11

    Topics: Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Luminescent Measurements; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5

    Topics: Bacteria; Bacterial Outer Membrane Proteins; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Culture Media; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Plasmids

1991
In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:2

    Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Imipenem; Meropenem; Methicillin Resistance; Staphylococcus aureus; Thienamycins

1991
Factors that influence the permeability assay of the outer membrane of Pseudomonas aeruginosa.
    FEMS microbiology letters, 1991, May-15, Volume: 64, Issue:2-3

    Topics: beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Diffusion; Enzyme Induction; Imipenem; Pseudomonas aeruginosa; Temperature

1991
[Recommendations for the indication-justified use of antibiotics. 1. beta-lactam antibiotics].
    Zeitschrift fur arztliche Fortbildung, 1991, Aug-12, Volume: 85, Issue:15

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; Cephalosporins; Cilastatin; Drug Combinations; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance

1991
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin

1991
The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activity.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:1

    Topics: Amphotericin B; Animals; Aztreonam; Bone Marrow Cells; Cephalosporins; Colony-Forming Units Assay; Evaluation Studies as Topic; Female; Humans; Imipenem; Mice; Mice, Inbred C57BL; Stem Cells

1991
[Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests

1990
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:4

    Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin

1990
Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.
    The Journal of infectious diseases, 1990, Volume: 162, Issue:4

    Topics: Amikacin; Blood Bactericidal Activity; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Complement C9; Complement System Proteins; Dose-Response Relationship, Drug; Humans; Imipenem; Lipopolysaccharides; Pseudomonas aeruginosa; Serum Bactericidal Test

1990
Monotherapy for empirical management of febrile neutropenic patients.
    NCI monographs : a publication of the National Cancer Institute, 1990, Issue:9

    Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Costs and Cost Analysis; Fever; Humans; Imipenem; Infections; Neutropenia; Quinolones

1990
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:8

    Topics: Bacteria; beta-Lactamases; Carbapenems; Cefpirome; Ceftazidime; Cephalosporins; Humans; Imipenem; Molecular Structure; Thienamycins

1990
[Combined antimicrobial preparations].
    Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48, Issue:10

    Topics: Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Penicillins

1990
[In vitro synergism of two-drug combinations among cefamandole, flomoxef and imipenem against MRSA].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:2

    Topics: Cefmetazole; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Imipenem; Methicillin; Penicillin Resistance; Staphylococcus aureus

1990
[Influence of Mueller-Hinton broth on the in vitro activities of cefuzoname, flomoxef, imipenem, and minocycline against Staphylococcus aureus].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:5

    Topics: Ceftizoxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Imipenem; Minocycline; Staphylococcus aureus; Tetracyclines

1990
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
    The Journal of antibiotics, 1990, Volume: 43, Issue:1

    Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections

1990
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:12

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Ticarcillin

1989
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
    Drugs under experimental and clinical research, 1989, Volume: 15, Issue:11-12

    Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Cephamycins; Hydrolysis; Imipenem; Isoenzymes; Kinetics; Klebsiella pneumoniae; Plasmids

1989
Cholangitis after the Kasai operation for biliary atresia.
    Journal of pediatric surgery, 1989, Volume: 24, Issue:8

    Topics: Anti-Bacterial Agents; Biliary Atresia; Cephalosporins; Cholangitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Infant; Methylprednisolone; Portoenterostomy, Hepatic; Postoperative Care; Postoperative Complications; Prognosis

1989
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Ceftibuten; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Respiratory Tract Infections

1989
In vitro evaluation of antibiotics for treatment of meningitis caused by Campylobacter fetus subspecies fetus.
    The Pediatric infectious disease journal, 1989, Volume: 8, Issue:9

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Cephalosporins; Child, Preschool; Chloramphenicol; Gentamicins; Humans; Imipenem; Infant, Newborn; Meningitis; Microbial Sensitivity Tests; Middle Aged

1989
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
    Chemotherapy, 1986, Volume: 32, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin

1986
Antimicrobial susceptibility of group B streptococci.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Quinolines; Streptococcus agalactiae; Thienamycins; Trimethoprim

1986
The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Thienamycins

1985
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; Thienamycins

1988
Serum bactericidal test in volunteers--a review.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:1

    Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Male; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins

1986
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1986, Volume: 5, Issue:1

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin

1986
In vitro activity of CGP 31608, a new penem.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Bacteroides; Carrier Proteins; Cephalosporins; Clostridium; Enterobacteriaceae; Haemophilus influenzae; Hexosyltransferases; Imipenem; Lactams; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Neisseria; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins

1987
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:11

    Topics: Aminoglycosides; beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance; Drug Stability; Gentamicins; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1988
[Third generation cephalosporins, monobactams and carbapenems].
    La Revue du praticien, 1988, Mar-10, Volume: 38, Issue:8

    Topics: Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Imipenem; Thienamycins

1988
Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams.
    Journal of clinical microbiology, 1988, Volume: 26, Issue:9

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Culture Media; Drug Therapy, Combination; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Sodium Chloride; Staphylococcus; Staphylococcus aureus; Ticarcillin

1988
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Pathology, 1988, Volume: 20, Issue:3

    Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillins; Ticarcillin

1988
Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:9

    Topics: Aeromonas; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Humans; Imipenem; Isoelectric Focusing; Male; Penicillins

1988
A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.
    The Biochemical journal, 1988, Oct-01, Volume: 255, Issue:1

    Topics: Aztreonam; beta-Lactamases; Cephalosporins; Hydrolysis; Imipenem; Kinetics; Moxalactam; Substrate Specificity

1988
In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:5

    Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Stability; Enterobacteriaceae; Enzyme Induction; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins

1987
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins

1986
Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Monobactams; Penicillin Resistance; Penicillins; Structure-Activity Relationship; Thienamycins

1986
Activity of newer antimicrobial agents against Aeromonas hydrophila.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:4

    Topics: Aeromonas; Anti-Bacterial Agents; Cephalosporins; Humans; Imipenem; Lactams; Monobactams; Penicillins; Quinolines; Thienamycins

1986
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
    Postgraduate medicine, 1987, Volume: 81, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin

1987
Comparative in vitro activities of ampicillin, BMY 28142, and imipenem against Mycobacterium avium complex.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:2

    Topics: Ampicillin; Cefepime; Cephalosporins; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium avium; Thienamycins

1987
The in-vivo postantibiotic effect of imipenem and other new antimicrobials.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Female; Half-Life; Imipenem; Kinetics; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thienamycins

1986
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin

1987
Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
    Journal of medical microbiology, 1986, Volume: 21, Issue:1

    Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Imipenem; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Moxalactam; Nephelometry and Turbidimetry; Thienamycins

1986
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:2

    Topics: Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Cefotaxime; Ceftazidime; Cephalosporins; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins

1986
In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
    Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:4

    Topics: Bacteria; Cefepime; Cephalosporins; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Mutation; Thienamycins

1985
In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Thienamycins

1985
Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.
    European journal of clinical microbiology, 1985, Volume: 4, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoxitin; Cephalosporins; Citrobacter; Culture Media; Enterobacter; Enterobacteriaceae; Enzyme Induction; Imipenem; Penicillin Resistance; Penicillins; Thienamycins

1985
Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cefpirome; Cephalosporins; Escherichia coli; Haemophilus influenzae; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus; Streptococcus; Thienamycins

1985
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
    Pathology, 1985, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin

1985
Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:4

    Topics: Anti-Bacterial Agents; Bordetella pertussis; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Thienamycins

1984
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:4

    Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam

1982
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
    Chemotherapy, 1982, Volume: 28, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin

1982
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins

1981
In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
    European journal of clinical microbiology, 1982, Volume: 1, Issue:5

    Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gardnerella vaginalis; Haemophilus; Imipenem; Microbial Sensitivity Tests; Nitroimidazoles; Quinolines; Quinolones; Thienamycins

1982
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
    Journal of clinical microbiology, 1984, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine

1984
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
    The Journal of infectious diseases, 1981, Volume: 143, Issue:3

    Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin

1981
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1980, Volume: 18, Issue:6

    Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa

1980
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
    Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam

1981
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:6

    Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam

1981
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:1

    Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity

1981
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Microbiology and immunology, 1981, Volume: 25, Issue:11

    Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens

1981
Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
    The Biochemical journal, 1981, Oct-01, Volume: 199, Issue:1

    Topics: Actinomycetaceae; Amdinocillin; beta-Lactams; Carboxypeptidases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Imipenem; Kinetics; Penicillanic Acid; Penicillins; Quinoxalines; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Zinc

1981
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Infection, 1982, Volume: 10, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin

1982
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam

1981
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections

1981
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4

    Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae

1981
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
    The Journal of antimicrobial chemotherapy, 1982, Volume: 9, Issue:5

    Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia

1982
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    European journal of clinical microbiology, 1982, Volume: 1, Issue:1

    Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins

1982
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:4

    Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Cefmenoxime; Cefotaxime; Cefotetan; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Thienamycins

1983
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Diagnostic microbiology and infectious disease, 1983, Volume: 1, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins

1983
Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:1

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Chloramphenicol; Haemophilus influenzae; Humans; Imipenem; Infant; Kinetics; Male; Meningitis, Haemophilus; Penicillin Resistance; Rabbits; Thienamycins

1984
In vitro activity of N-formimidoyl thienamycin (MK 0787) compared with other beta-lactamase stable cephalosporins against beta-lactamase producing Staphylococcus aureus.
    The Indian journal of medical research, 1984, Volume: 79

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Staphylococcus aureus; Thienamycins

1984
[Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Immunitat und Infektion, 1984, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Enterobacter; Enterobacteriaceae; Enzyme Induction; Imipenem; Lactams; Penicillin Resistance; Penicillins; Thienamycins

1984
In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 11, Issue:4

    Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Imipenem; Serratia marcescens; Thienamycins

1983
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:4

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chloramphenicol; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Thienamycins; Time Factors

1984
Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 11, Issue:6

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gentamicins; Imipenem; Pseudomonas aeruginosa; Thienamycins

1983
Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 12, Issue:4

    Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cephalosporins; Conjugation, Genetic; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Thienamycins

1983
The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
    Journal of medical microbiology, 1984, Volume: 17, Issue:2

    Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Microscopy, Electron; Nephelometry and Turbidimetry; Pseudomonas aeruginosa; Spheroplasts; Thienamycins

1984
[Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
    Pathologie-biologie, 1984, Volume: 32, Issue:5

    Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Imipenem; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Thienamycins; Ticarcillin

1984
In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter fetus; Campylobacter Infections; Cefoperazone; Cephalosporins; Chickens; Humans; Imipenem; Lactams; Leucomycins; Microbial Sensitivity Tests

1981
In vitro activity of HR 810, a new cephalosporin.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefpirome; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Thienamycins

1984
Trends in the development of beta-lactam antibiotics.
    Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42

    Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Humans; Imipenem; Penicillins; Technology, Pharmaceutical; Thienamycins

1984
Comparative stability of first, second and third generation cephalosporins and N-formimidoyl thienamycin against gram-negative beta-lactamases.
    Arzneimittel-Forschung, 1983, Volume: 33, Issue:9

    Topics: beta-Lactamases; Cephalosporins; Drug Stability; Gram-Negative Bacteria; Imipenem; Thienamycins

1983
Stability of N-formimidoylthienamycin in aqueous solution.
    Journal of pharmaceutical sciences, 1981, Volume: 70, Issue:3

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Stability; Hydrogen-Ion Concentration; Imipenem; Kinetics; Lactams; Penicillins; Phosphates; Solutions

1981
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cross Infection; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Sepsis

1982
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:6

    Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Culture Media; Imipenem; Microbial Sensitivity Tests; Mycobacterium; Thienamycins

1982
In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins.
    Chemotherapy, 1982, Volume: 28, Issue:4

    Topics: beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Imipenem; Pseudomonas; Thienamycins

1982
In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:6

    Topics: Anti-Bacterial Agents; Cephalosporins; Imipenem; Lactams; Microbial Sensitivity Tests; Nocardia asteroides

1981
Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
    Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:7

    Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Infant; Male; Meningitis, Pneumococcal; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins

1995
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
    Pathologie-biologie, 1995, Volume: 43, Issue:4

    Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins

1995
Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
    The Journal of antibiotics, 1995, Volume: 48, Issue:8

    Topics: Animals; Ceftazidime; Cephalosporins; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1995
Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
    The Journal of pediatrics, 1995, Volume: 127, Issue:1

    Topics: beta-Lactam Resistance; Cefuroxime; Cephalosporins; Child; Humans; Imipenem; Male; Meningitis, Pneumococcal; Penicillins; Streptococcus pneumoniae; Vancomycin

1995
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1995, Volume: 14, Issue:3

    Topics: Aztreonam; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity

1995
[A clinical study on chemotherapies for chorioamnionitis].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:12

    Topics: Amoxicillin; Ceftazidime; Cephalosporins; Chorioamnionitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fetal Membranes, Premature Rupture; Humans; Imipenem; Obstetric Labor, Premature; Pregnancy

1994
Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis.
    Hinyokika kiyo. Acta urologica Japonica, 1994, Volume: 40, Issue:8

    Topics: Animals; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Female; Imipenem; Kidney Calculi; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Urinary Bladder Calculi; Urinary Calculi; Urinary Tract Infections

1994
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
    Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:1

    Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests

1994
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
    Journal of medical microbiology, 1994, Volume: 40, Issue:6

    Topics: Aged; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Mutation

1994
[Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus

1994
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus

1994
[Transfer of resistance to new cephalosporins and carbapenems (Imipenem)].
    Ceskoslovenska epidemiologie, mikrobiologie, imunologie, 1994, Volume: 43, Issue:1

    Topics: Cephalosporins; Drug Resistance, Microbial; Imipenem; R Factors

1994
Substrate-induced inactivation of the OXA2 beta-lactamase.
    The Biochemical journal, 1993, Nov-01, Volume: 295 ( Pt 3)

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enzyme Activation; Hydrolysis; Imipenem; Kinetics; Penicillins

1993
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests

1993
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Scandinavian journal of infectious diseases. Supplementum, 1993, Volume: 91

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence

1993
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:6

    Topics: Amikacin; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Fusidic Acid; Gentamicins; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Staphylococcus aureus

1993
[In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:2

    Topics: Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Staphylococcus aureus

1993
[A nationwide survey of antimicrobial susceptibilities of clinical isolates to antibiotics in Japan (1988-1990)].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cephalosporins; Humans; Imipenem; Japan; Microbial Sensitivity Tests; Penicillins; Time Factors

1993
Cephalosporins having a heterocyclic catechol in the C3 side chain. I. Enhancement of efficacy against gram-negative bacteria.
    The Journal of antibiotics, 1993, Volume: 46, Issue:5

    Topics: Animals; Ceftazidime; Cephalosporins; Half-Life; Imipenem; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship

1993
In vitro activity of tosufloxacin against Pseudomonas pseudomallei, Salmonella spp. and other Enterobacteriaceae.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Anti-Infective Agents; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Enterobacteriaceae; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Naphthyridines; Salmonella; Thienamycins

1995
Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:12

    Topics: Bacterial Proteins; Bacteriolysis; Base Sequence; Carrier Proteins; Cefotiam; Cephalosporins; Drug Synergism; Hexosyltransferases; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Polymerase Chain Reaction; Staphylococcus aureus; Thienamycins

1995
Impact of different classes antimicrobial agents on plasma endotoxin activity.
    Archives of surgery (Chicago, Ill. : 1960), 1996, Volume: 131, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins

1996
In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Microbios, 1995, Volume: 84, Issue:339

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chromogenic Compounds; Drug Resistance, Microbial; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Slovakia; Thienamycins

1995
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:1

    Topics: Anti-Infective Agents; Bacteremia; Bacterial Outer Membrane Proteins; Ceftazidime; Cephalosporins; Ciprofloxacin; Humans; Imipenem; Pseudomonas aeruginosa; Thienamycins

1996
[Nephrotoxicity and drug interaction of vancomycin (2)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 107, Issue:5

    Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin

1996
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins

1996
[In vitro and in vivo antibacterial activities of sulopenem, a new penem antibiotic].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Lactams; Male; Meropenem; Mice; Thienamycins

1996
[In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; beta-Lactams; Cecum; Cefoperazone; Ceftizoxime; Cephalosporins; Clostridioides difficile; Drug Stability; Drug Therapy, Combination; Imipenem; Lactams; Male; Mice; Mice, Inbred ICR; Sulbactam; Thienamycins

1996
[Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4

    Topics: Ampicillin; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Escherichia coli; Humans; Imipenem; Listeria monocytogenes; Meningitis, Bacterial; Meropenem; Penicillins; Sepsis; Streptococcus agalactiae; Streptococcus pneumoniae; Thienamycins

1996
Direct application of Etest to gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data.
    Diagnostic microbiology and infectious disease, 1996, Volume: 25, Issue:1

    Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Culture Media; Erythromycin; Gentamicins; Gram-Positive Cocci; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillins; Thienamycins; Vancomycin

1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin

1996
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin

1996
Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10

    Topics: Carbapenems; Ceftazidime; Cephalosporins; Endotoxins; Imipenem; Lipopolysaccharides; Lymphotoxin-alpha; Meropenem; Nitric Oxide; Pseudomonas aeruginosa; Thienamycins; Tumor Necrosis Factor-alpha

1996
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacter; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospital Bed Capacity; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Lung; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Wounds and Injuries

1996
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.
    The Journal of infectious diseases, 1996, Volume: 174, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins

1996
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:6

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin

1996
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Hydrolysis; Imipenem; Kinetics; Mutation

1997
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3

    Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections

1997
In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    The Journal of antibiotics, 1997, Volume: 50, Issue:2

    Topics: Animals; Carbapenems; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Imipenem; In Vitro Techniques; Male; Meropenem; Mice; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1997
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

1997
Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:2

    Topics: Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

1997
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin

1997
Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem.
    Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Follow-Up Studies; Imipenem; Injections; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Swine; Thienamycins; Vitreous Body

1997
In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococci.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Piperacillin; Teicoplanin; Vancomycin

1997
Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.
    Gut, 1997, Volume: 40, Issue:4

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Capillaries; Cefotaxime; Cephalosporins; Disease Progression; Imipenem; Male; Necrosis; Pancreas; Pancreatitis, Acute Necrotizing; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thienamycins

1997
[The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
    Casopis lekaru ceskych, 1997, Mar-12, Volume: 136, Issue:5

    Topics: Acinetobacter; Bacteria; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Imipenem; Pseudomonas; R Factors; Thienamycins; Xanthomonas

1997
Evolution of extended spectrum cephalosporin resistance in the pneumococcus.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:6

    Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Imipenem; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins

1997
Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii.
    FEMS microbiology letters, 1997, Aug-15, Volume: 153, Issue:2

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Enzyme Inhibitors; Hydrolysis; Imipenem; Isoelectric Point; Kinetics; Lactams; Molecular Weight; Oxacillin; Penicillins; Sodium Chloride; Substrate Specificity; Thienamycins

1997
Clostridium difficile infection in obstetric and gynecologic patients.
    Southern medical journal, 1997, Volume: 90, Issue:9

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting

1997
[Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:8

    Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins

1997
Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
    Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pseudomonas Infections; Swine; Vitreous Body

1997
Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Interactions; Drug Resistance, Multiple; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

1997
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12

    Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins

1997
Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis.
    Laboratory animal science, 1997, Volume: 47, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ceftazidime; Cephalosporins; Diarrhea; Disease Models, Animal; Female; Guinea Pigs; Imipenem; Meropenem; Movement Disorders; Neutropenia; Predictive Value of Tests; Pseudomonas Infections; Regression Analysis; Respiration; Thienamycins; Time Factors; Tobramycin; Weight Loss

1997
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam

1997
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
    The Journal of infection, 1997, Volume: 35, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed

1997
Cerebral nocardia abscesses in a patient with AIDS: correlation of magnetic resonance and white cell scanning images with neuropathological findings.
    The Journal of infection, 1997, Volume: 35, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Magnetic Resonance Imaging; Male; Nocardia asteroides; Nocardia Infections; Radionuclide Imaging; Thienamycins

1997
Activity of cefepime against resistant strains of Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:6

    Topics: beta-Lactam Resistance; Cefepime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

1997
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries

1997
[Pneumococcal infections: penicillin resistance and therapeutic implications].
    La Tunisie medicale, 1995, Volume: 73, Issue:2

    Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Erythromycin; Humans; Imipenem; Patient Care Planning; Penicillin G; Penicillin Resistance; Penicillins; Pleural Effusion; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Tetracycline Resistance; Thienamycins; Tracheal Diseases

1995
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1998, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin

1998
[The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serotyping; Sputum; Thienamycins

1998
Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Ceftazidime; Cephalosporins; Galactose; Hexosyltransferases; Imipenem; Lipopolysaccharides; Membranes; Microbial Sensitivity Tests; Models, Biological; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Salmonella typhi; Time Factors

1998
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin

1998
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
    Archives of internal medicine, 1998, Apr-27, Volume: 158, Issue:8

    Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome

1998
[Drug susceptibility of clinically isolated Helicobacter pylori].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins

1998
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 58, Issue:4

    Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E

1998
Further studies of transferable antibiotic resistance in strains of Pseudomonas aeruginosa from four clinical settings in three countries.
    Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:3

    Topics: Antibiotics, Antitubercular; Cefotaxime; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Humans; Imipenem; Proteus mirabilis; Pseudomonas aeruginosa; Rifampin; Thienamycins

1998
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:7

    Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins

1998
Cefepime--assessment of its need at a tertiary care center.
    Journal of clinical pharmacy and therapeutics, 1998, Volume: 23, Issue:1

    Topics: Adult; Aged; Anti-Infective Agents; Cefepime; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Cohort Studies; Drug Utilization Review; Female; Hospitals, University; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Switzerland; Thienamycins

1998
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
    JPMA. The Journal of the Pakistan Medical Association, 1998, Volume: 48, Issue:6

    Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pakistan; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination

1998
Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1998, Volume: 97, Issue:10

    Topics: Anti-Infective Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Ciprofloxacin; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Thienamycins

1998
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:12

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins

1998
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:9

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins

1998
Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:10

    Topics: Adult; Aged; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Thienamycins

1998
Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.
    The Western journal of medicine, 1998, Volume: 169, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Female; Humans; Imipenem; Infant; Male; Middle Aged; Penicillin Resistance; Pneumococcal Infections; Prevalence; Risk Factors; Serotyping; Streptococcus pneumoniae; Thienamycins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Washington

1998
[Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
    Pathologie-biologie, 1998, Volume: 46, Issue:8

    Topics: Animals; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Colony Count, Microbial; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Spleen; Thienamycins

1998
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
    Journal of dermatological science, 1999, Volume: 19, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin

1999
Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin.
    International journal of antimicrobial agents, 1998, Volume: 10, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Carbenicillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Geography; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Urinary Tract Infections

1998
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
    International journal of antimicrobial agents, 1998, Volume: 10, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Fusobacterium; Imipenem; Lactams; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Veillonella

1998
Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:11

    Topics: Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Humans; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1998
Comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:2

    Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Fever; Humans; Imipenem; Sulbactam; Thienamycins

1999
[Effects of isepamicin and beta-lactam antibiotics on the release of endotoxin from Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:1

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Endotoxins; Gentamicins; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins

1999
[Sensitivity to selected beta-lactam antibiotics of clinical strains of Escherichia coli and Klebsiella pneumoniae].
    Medycyna doswiadczalna i mikrobiologia, 1998, Volume: 50, Issue:3-4

    Topics: Anti-Bacterial Agents; Bacteriological Techniques; Body Fluids; Cephalosporins; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillin Resistance; Reproducibility of Results; Species Specificity

1998
Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A

    Topics: Aged; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin; Predictive Value of Tests; Respiratory Tract Infections; Thienamycins; Treatment Outcome

1999
Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefamandole; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Enterobacter cloacae; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

1999
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins

1999
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar

1999
Endotoxin release due to ciprofloxacin measured by three different methods.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:4

    Topics: Anti-Infective Agents; Bacterial Toxins; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Humans; Imipenem; Limulus Test; Lipopolysaccharides; Monocytes; Sensitivity and Specificity; Thienamycins; Tumor Necrosis Factor-alpha

1999
In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Wiener klinische Wochenschrift, 1999, Jul-30, Volume: 111, Issue:14

    Topics: Acinetobacter; Anti-Bacterial Agents; Austria; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonadaceae; Tazobactam; Thienamycins

1999
[Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:7

    Topics: Anti-Infective Agents; beta-Lactam Resistance; Carbapenems; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Ofloxacin; Pseudomonas aeruginosa; Thienamycins

1999
Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners.
    Toxicology, 1999, Nov-05, Volume: 138, Issue:2

    Topics: Animals; Carbapenems; Cefazolin; Cephalosporins; GABA Agonists; Imipenem; Injections, Intraventricular; Male; Meropenem; Mice; Mice, Inbred ICR; Muscimol; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Synaptic Membranes; Thienamycins

1999
Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Paris

1999
Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
    Pharmacotherapy, 1999, Volume: 19, Issue:12

    Topics: Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors

1999
Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:2

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins

2000
[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:12

    Topics: Bacteria; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Penicillins; Piperacillin; Respiratory Tract Infections; Thienamycins; Time Factors

1999
[Antimicrobial activities of meropenem against clinically isolated strains in 1997].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:12

    Topics: Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Thienamycins; Time Factors

1999
Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:3

    Topics: Bacterial Typing Techniques; beta-Lactamases; Cefpirome; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Fatal Outcome; France; Humans; Imipenem; Male; Microbial Sensitivity Tests; Thienamycins; Trachea; Urine

2000
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.
    International journal of antimicrobial agents, 2000, Volume: 14, Issue:1

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Forecasting; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Time Factors

2000
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate

2000
Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.
    Infection and immunity, 2000, Volume: 68, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Cell Adhesion; Cell Movement; Cephalosporins; Dexamethasone; Endothelium, Vascular; Escherichia coli; Female; Galactosamine; Imipenem; Kinetics; Leukocytes; Male; Mice; Microcirculation; Rats; Rats, Sprague-Dawley; Sepsis; Staphylococcus aureus; Thienamycins; Time Factors; Tumor Necrosis Factor-alpha

2000
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin

2000
In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:6

    Topics: Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

2000
Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Escherichia coli; Humans; Imipenem; Microbial Sensitivity Tests; Porins

2000
Imipenem therapy for septicemic melioidosis in a child with penicillin and cephalosporin adverse reaction.
    The Southeast Asian journal of tropical medicine and public health, 2000, Volume: 31, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Diabetes Complications; Drug Therapy, Combination; Humans; Imipenem; Male; Melioidosis; Thienamycins

2000
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins

2000
[Evaluation of antibiotics by the method of initial bactericidal activity].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

2000
In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4

    Topics: Amikacin; Animals; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Survival Analysis

2001
Case-control study of risk factors for the development of enterococcal bacteremia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2

    Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins

2001
Comparative in vitro antimicrobial activity of a new carbapenem, E1010, and tentative disc diffusion test interpretative criteria.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Diffusion; Enterobacteriaceae; Imipenem; Meropenem; Microbial Sensitivity Tests; Pyrrolidines; Thienamycins

2001
Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone.
    Journal of Korean medical science, 2001, Volume: 16, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Korea; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Vancomycin Resistance

2001
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:7

    Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin

2001
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9

    Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam

2001
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:9

    Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins

2001
In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cephalosporins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

2002
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
    Chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins

2001
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method].
    Zhonghua yi xue za zhi, 2000, Volume: 80, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin

2000
In vitro activity of meropenem and four other antibiotics against 554 clinical strains obtained from Beijing in 1999.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2000, Volume: 6, Issue:3

    Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Meropenem; Thienamycins

2000
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
    International journal of antimicrobial agents, 2002, Volume: 19, Issue:2

    Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin

2002
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins

2001
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
    Oral microbiology and immunology, 2002, Volume: 17, Issue:2

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases

2002
[Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:1

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Imipenem; Meropenem; Mutation; Pseudomonas aeruginosa; Thienamycins

2002
A luminescent Escherichia coli biosensor for the high throughput detection of beta-lactams.
    Journal of biomolecular screening, 2002, Volume: 7, Issue:2

    Topics: Ampicillin; Anti-Bacterial Agents; Biosensing Techniques; Cefoxitin; Cephalosporins; Cephamycins; Cephapirin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Escherichia coli; Imipenem; Inhibitory Concentration 50; Light; Luciferases; Oxacillin; Penicillins; Piperacillin; Plasmids; Thienamycins; Time Factors

2002
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins

2002
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:3

    Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins

2002
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
    Oral microbiology and immunology, 2002, Volume: 17, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam

2002
[The isolation of Pseudomonas aeruginosa from burn wound and the analysis of its antibiotic resistant spectrum].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2002, Volume: 18, Issue:5

    Topics: Burns; Cephalosporins; Drug Resistance, Bacterial; Enzyme Induction; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2002
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Common Bile Duct; Disease Susceptibility; Female; Gallstones; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Penicillins; Treatment Outcome

2003
[Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
    Medicina, 2003, Volume: 63, Issue:1

    Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Argentina; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies

2003
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF).
    Wiener medizinische Wochenschrift (1946), 2003, Volume: 153, Issue:7-8

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure

2003
Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli.
    Yonsei medical journal, 2003, Aug-30, Volume: 44, Issue:4

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Negative Bacteria; Humans; Imipenem; Korea; Vancomycin Resistance

2003
Lack of efflux mechanism in a clinical isolate of Pseudomonas aeruginosa highly resistant to beta-lactams and imipenem.
    Folia microbiologica, 2003, Volume: 48, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Cefepime; Ceftazidime; Ceftriaxone; Cell Membrane Permeability; Cephalosporins; Conjugation, Genetic; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Humans; Imipenem; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa

2003
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
    Kekkaku : [Tuberculosis], 2003, Volume: 78, Issue:9

    Topics: Carbapenems; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Thienamycins; Tuberculosis, Pulmonary

2003
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Logistic Models; Male; Middle Aged; Risk Factors; Thienamycins

2004
Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001.
    Journal of Korean medical science, 2004, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus faecium; Humans; Imipenem; Klebsiella pneumoniae; Korea; Pseudomonas aeruginosa; Time Factors; Vancomycin

2004
[The trend and susceptibility to antibacterial agents of enterococcus species from urinary tract infections].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2004, Volume: 95, Issue:1

    Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cefozopran; Cefpirome; Cephalosporins; Cilastatin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Humans; Imipenem; Microbial Sensitivity Tests; Urinary Tract Infections

2004
Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes.
    Biochemical and biophysical research communications, 2004, May-07, Volume: 317, Issue:3

    Topics: Bacterial Outer Membrane Proteins; Base Sequence; Cefepime; Cefpirome; Cephalosporins; DNA Primers; Drug Resistance, Microbial; Enterobacter aerogenes; Imipenem; Mutation

2004
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins

2004
Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli.
    Diagnostic microbiology and infectious disease, 2004, Volume: 49, Issue:1

    Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acid; Culture Media, Conditioned; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity

2004
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    International journal of antimicrobial agents, 2004, Volume: 23, Issue:6

    Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam

2004
Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin

2004
Case report: Pseudomonas aeruginosa-related intervertebral discitis in a young boy with medulloblastoma.
    Journal of neuro-oncology, 2004, Volume: 68, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Back Pain; Biopsy, Fine-Needle; Bone Neoplasms; Cefepime; Cephalosporins; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Diagnosis, Differential; Discitis; Drug Therapy, Combination; Humans; Imipenem; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Medulloblastoma; Pseudomonas Infections; Thoracic Vertebrae; Treatment Outcome

2004
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome

2005
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection.
    Surgical infections, 2004,Fall, Volume: 5, Issue:3

    Topics: Adult; Aged; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Imipenem; Male; Metronidazole; Middle Aged; Probability; Retrospective Studies; Treatment Outcome

2004
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures.
    Chest, 2005, Volume: 127, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Early Diagnosis; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Population Surveillance; Practice Guidelines as Topic; Prospective Studies; Pseudomonas Infections; Treatment Outcome; Ventilators, Mechanical

2005
[Imipenem and cefepime in empirical therapy of infectious complications after radical surgeries in patients with invasive cancer of the urinary bladder].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:8-9

    Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cystectomy; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasm Staging; Postoperative Complications; Retrospective Studies; Urinary Bladder Neoplasms; Urinary Tract Infections

2004
[Germs that produce the extended spectrum betalactamases].
    La Tunisie medicale, 2004, Volume: 82, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors

2004
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Disease Models, Animal; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Treatment Outcome

2005
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
    Critical care medicine, 2005, Volume: 33, Issue:10

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins

2005
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams.
    International journal of antimicrobial agents, 2006, Volume: 27, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies

2006
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome

2006
Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
    Japanese journal of infectious diseases, 2006, Volume: 59, Issue:3

    Topics: Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Taiwan

2006
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:3

    Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin

2006
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Membrane Transport Proteins; Meropenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Thienamycins; Thigh; Treatment Outcome

2007
Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:5

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Computer Simulation; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Hungary; Imipenem; Infusions, Intravenous; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2006
Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
    Medical science monitor : international medical journal of experimental and clinical research, 2006, Volume: 12, Issue:11

    Topics: Anti-Infective Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Imipenem; Iran; Klebsiella pneumoniae; Male; Meropenem; Thienamycins

2006
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:1

    Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey

2007
Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela.
    Medical science monitor : international medical journal of experimental and clinical research, 2007, Volume: 13, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Gentamicins; Humans; Imipenem; Infant, Newborn; Tetracyclines; Venezuela

2007
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins

2007
Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:3

    Topics: Amino Acids; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cloning, Molecular; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Hydrolysis; Imipenem; Kinetics; Microbial Sensitivity Tests; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Transformation, Bacterial

2007
Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
    JPMA. The Journal of the Pakistan Medical Association, 2007, Volume: 57, Issue:10

    Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Developing Countries; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; Humans; Imipenem; Intensive Care Units; Medical Order Entry Systems; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Program Development; Vancomycin

2007
Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Dec-15, Volume: 860, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Burns; Calibration; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Imipenem; Male; Middle Aged; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Vancomycin

2007
Research and clinical value of antibacterial-application software.
    Chinese medical journal, 2008, Jan-05, Volume: 121, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software

2008
In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Pharmacotherapy, 2008, Volume: 28, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Escherichia coli; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline

2008
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary

2008
Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
    FEMS microbiology letters, 2008, Volume: 282, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Porins

2008
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins

2008
[Epidemiological study on cigar-shaped clostridia isolated in a local Japanese general hospital].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Clostridium; Clostridium Infections; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, General; Humans; Imipenem; Japan; Male; Penicillins

2008
Diversity of antimicrobial use and resistance in 42 hospitals in the United States.
    Pharmacotherapy, 2008, Volume: 28, Issue:7

    Topics: Anti-Bacterial Agents; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Utilization Review; Fluoroquinolones; Humans; Imipenem; Methicillin; Multivariate Analysis; United States

2008
[Surveillance of multidrug resistant bacteria in a Tunisian hospital].
    La Tunisie medicale, 2008, Volume: 86, Issue:11

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Burns; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pseudomonas aeruginosa; Retrospective Studies; Sentinel Surveillance; Staphylococcus aureus; Tunisia

2008
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
    Bosnian journal of basic medical sciences, 2009, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin

2009
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
    BMC infectious diseases, 2009, Apr-12, Volume: 9

    Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure

2009
Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 5

    Topics: Anti-Bacterial Agents; Automation; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Genetic Predisposition to Disease; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Algeria; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Piperacillin; Polymerase Chain Reaction; Proteus vulgaris; Providencia

2009
[Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; R Factors; Substrate Specificity

2010
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
    Pharmacotherapy, 2009, Volume: 29, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors

2009
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
    Journal of infection in developing countries, 2008, Jun-01, Volume: 2, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela

2008
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins

2009
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
    Yonsei medical journal, 2009, Dec-31, Volume: 50, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests

2009
Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftazidime; Cephalosporins; Electrophoresis, Polyacrylamide Gel; Imipenem; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Pseudomonas aeruginosa

2010
Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Microbial Sensitivity Tests; Species Specificity

2010
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
    Journal of infection and public health, 2010, Volume: 3, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin

2010
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline

2011
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:6

    Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins

2011
Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cephalothin; Crystallography, X-Ray; Escherichia coli; Imipenem; Magnetic Resonance Spectroscopy; Meropenem; Penicillin G; Thienamycins

2011
Bacteriology of infection in severe acute pancreatitis.
    JOP : Journal of the pancreas, 2011, Jan-05, Volume: 12, Issue:1

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cephalosporins; Comorbidity; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatitis; Prevalence; Prospective Studies; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome

2011
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa

2011
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Imipenem; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins

2011
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
    International journal of medical sciences, 2011, Volume: 8, Issue:4

    Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin

2011
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:3

    Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh

2011
Inhibitory effects of various essential oils and individual components against extended-spectrum beta-lactamase (ESBL) produced by Klebsiella pneumoniae and their chemical compositions.
    Journal of food science, 2011, Volume: 76, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Food Preservatives; Gas Chromatography-Mass Spectrometry; Imipenem; Klebsiella pneumoniae; Lamiaceae; Mentha piperita; Microbial Sensitivity Tests; Ocimum basilicum; Ofloxacin; Oils, Volatile; Origanum; Plant Extracts; Satureja

2011
Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; DNA-Binding Proteins; DNA, Bacterial; Histones; Humans; Imipenem; Integrons; Klebsiella oxytoca; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Alignment; Spain; Thienamycins

2012
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections

2012
Microbiologic characteristics of pathogenic bacteria from hospitalized trauma patients who survived Wenchuan earthquake.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; China; Disasters; Drug Resistance, Bacterial; Earthquakes; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Hospitalization; Humans; Imipenem; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Survival; Trauma Centers; Wounds and Injuries; Young Adult

2012
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2012, Volume: 57, Issue:3-4

    Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin

2012
Functional characterization of a novel Mn2+ dependent protein serine/threonine kinase KpnK, produced by Klebsiella pneumoniae strain MGH78578.
    FEBS letters, 2012, Nov-02, Volume: 586, Issue:21

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cations, Divalent; Cephalosporins; Coenzymes; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gene Deletion; Gene Expression; Hydrogen-Ion Concentration; Imipenem; Klebsiella pneumoniae; Manganese; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphorylation; Protein Serine-Threonine Kinases; Recombinant Proteins; Signal Transduction; Stress, Physiological

2012
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.
    Surgical infections, 2013, Volume: 14, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies

2013
Phenotypic and molecular characterization of extended-spectrum β-lactamases and AmpC β-lactamases in Klebsiella pneumoniae.
    Pakistan journal of pharmaceutical sciences, 2013, Volume: 26, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Egypt; Genotype; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Phenotype; Polymerase Chain Reaction; Sequence Analysis, DNA; Tigecycline

2013
When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents.
    Clinical therapeutics, 2013, Volume: 35, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Drug Costs; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2013
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
    BMC infectious diseases, 2013, Nov-06, Volume: 13

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult

2013
[Analysis of the carbapenemase-producing mechanism of Enterobacteriaceae with decreased susceptibility to carbapenems].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Ertapenem; Gene Amplification; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins

2013
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins

2014
Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Imipenem; Infection Control; Inosine Monophosphate; Japan; Male; Meropenem; Middle Aged; Phylogeny; R Factors; Retrospective Studies; Risk Factors; Tertiary Healthcare; Thienamycins

2014
In vivo efficacy of ceftolozane against Pseudomonas aeruginosa in a rabbit experimental model of pneumonia: comparison with ceftazidime, piperacillin/tazobactam and imipenem.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:3

    Topics: Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; Ceftazidime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Female; Humans; Imipenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Treatment Outcome

2014
The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Program Evaluation; Pseudomonas aeruginosa; Spain; Thienamycins

2015
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    The Journal of antibiotics, 2015, Volume: 68, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins

2015
War wound treatment complications due to transfer of an IncN plasmid harboring bla(OXA-181) from Morganella morganii to CTX-M-27-producing sequence type 131 Escherichia coli.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Morganella morganii; Plasmids

2015
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:5

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins

2017
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs

2015
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
    Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection

2016
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
    Xenobiotica; the fate of foreign compounds in biological systems, 2016, Volume: 46, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin

2016
Antibiotic Resistance Patterns of Gram-Negative Psychrotrophic Bacteria from Bulk Tank Milk.
    Journal of food science, 2016, Volume: 81, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Food Microbiology; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Milk; Pseudomonadaceae; Thienamycins

2016
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Thienamycins; Treatment Outcome

2016
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cefepime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Taiwan; Thienamycins

2016
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
    Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult

2017
Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran.
    Infectious disorders drug targets, 2016, Volume: 16, Issue:3

    Topics: Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections

2016
[Study on drug sensitivity against Comamonas testosteroni by Kirby-Bauer disk diffusion method].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2016, Volume: 41, Issue:8

    Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Comamonas testosteroni; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins

2016
Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
    Journal of Korean medical science, 2016, Volume: 31, Issue:11

    Topics: Acute Disease; Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Prostatitis; Republic of Korea; Retrospective Studies; Risk Factors

2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Journal of medical microbiology, 2017, Volume: 66, Issue:1

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections

2017
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
    BMC infectious diseases, 2017, 01-17, Volume: 17, Issue:1

    Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin

2017
Trends in Drug Resistance of
    Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2017
IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Gene Transfer, Horizontal; Humans; Imipenem; Klebsiella; Meropenem; Plasmids; Thienamycins; United Kingdom

2017
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 65

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Ertapenem; Gentamicins; Humans; Imipenem; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Tigecycline

2017
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    The Journal of antimicrobial chemotherapy, 2017, Nov-01, Volume: 72, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalosporins; Drug Stability; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins

2017
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1

    Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2017
The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis.
    Nature communications, 2017, 12-21, Volume: 8, Issue:1

    Topics: beta-Lactamases; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Escherichia coli; Hydrolysis; Imipenem; Magnetic Resonance Spectroscopy; Meropenem; Models, Molecular; Penicillins; Thienamycins

2017
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
    Current microbiology, 2018, Volume: 75, Issue:8

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Combinations; Drug Resistance, Bacterial; Gentamicins; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Rifampin; Streptococcus mitis; Streptococcus oralis; Trimethoprim, Sulfamethoxazole Drug Combination

2018
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:3

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult

2018
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
    Zhonghua wei zhong bing ji jiu yi xue, 2016, Volume: 28, Issue:5

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins

2016
Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
    The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Chromosomes, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2018
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
    JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam

2018
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream
    The Journal of antimicrobial chemotherapy, 2019, 02-01, Volume: 74, Issue:2

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Taiwan; Tazobactam

2019
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics.
    Nature communications, 2018, 10-30, Volume: 9, Issue:1

    Topics: Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cephalosporins; Codon; Drug Resistance, Bacterial; Escherichia coli; High-Throughput Nucleotide Sequencing; Imipenem; Mutation; Penicillins

2018
The Occurrence of bla
    Infectious disorders drug targets, 2020, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Trimethoprim, Sulfamethoxazole Drug Combination

2020
Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus.
    Scientific reports, 2020, Jan-27, Volume: 10, Issue:1

    Topics: Amoxicillin; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Plasmids

2020
Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2020, Volume: 38, Issue:10

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2020
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United State
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 06-15, Volume: 72, Issue:12

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States

2021
Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 06-15, Volume: 72, Issue:12

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Imipenem; Phenotype; Tazobactam

2021
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2020
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Tazobactam

2020
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult

2021
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022, Volume: 41, Issue:2

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Imipenem; Jupiter; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2022
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 113

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam

2021
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales.
    Diagnostic microbiology and infectious disease, 2022, Volume: 102, Issue:1

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tazobactam

2022
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
    The Journal of antimicrobial chemotherapy, 2022, 03-31, Volume: 77, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2022
    Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States

2022
T405, a New Penem, Exhibits
    Antimicrobial agents and chemotherapy, 2022, 06-21, Volume: 66, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous

2022
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient.
    Journal of global antimicrobial resistance, 2022, Volume: 30

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2022
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2022, 09-30, Volume: 77, Issue:10

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Borinic Acids; Carboxylic Acids; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Cyclooctanes; Humans; Imipenem; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2022
Clinical Characteristics and Drug Resistance Analysis of 90 Cases of Children with Salmonella Enteritis.
    Computational and mathematical methods in medicine, 2022, Volume: 2022

    Topics: Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Drug Resistance; Enteritis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Retrospective Studies

2022
    Antimicrobial agents and chemotherapy, 2022, 10-18, Volume: 66, Issue:10

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2022
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
    BMC microbiology, 2022, 10-01, Volume: 22, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline

2022
Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa.
    Scientific reports, 2022, 10-07, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Monobactams; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2022
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
    Current microbiology, 2022, Oct-15, Volume: 79, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2022
Prevalence of Efflux Pump and Porin-Related Antimicrobial Resistance in Clinical
    Archives of Razi Institute, 2022, Volume: 77, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefepime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Iraq; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Prevalence

2022
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland-SMART 2017-2020.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:3

    Topics: Anti-Bacterial Agents; Cephalosporins; Czech Republic; Humans; Hungary; Imipenem; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023
Biochemical Insights into Imipenem Collateral Susceptibility Driven by
    Antimicrobial agents and chemotherapy, 2023, 02-16, Volume: 67, Issue:2

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021).
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
    The Journal of antimicrobial chemotherapy, 2023, 05-03, Volume: 78, Issue:5

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporinase; Cephalosporins; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Doripenem; Humans; Imipenem; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023